Table 2.
EOS-24 presented with data for recall period selection and item reduction. Table contains all diagnoses (n = 153).
| EOS-24 |
Item group | Comparison of Recall periods |
Recall period of 3 months |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Original items (24 pc.) | 2 weeks mean (SD) | 3 months mean (SD) | 6 months mean (SD) | Min | Max | % N (Q1–Q21) or 0 (Q22–24) | ITC | ||||
| 1. I have had pain in my ear. | Ear symptoms | 0.65 | (0.98) | 0.95 | (1.12) | 1.12 | (1.24) | 0 | 4 | 33.7 | 0.527 |
| 2. I have had an itch in my ear. | Ear symptoms | 0.99 | (1.20) | 1.02 | (1.21) | 1.09 | (1.26) | 0 | 4 | 27.0 | 0.541 |
| 3. I have felt pressure in my ear. | Ear symptoms | 0.87 | (1.16) | 1.00 | (1.12) | 1.03 | (1.14) | 0 | 4 | 31.3 | 0.632 |
| 4. I have felt moisture in my ear. | Ear symptoms | 0.86 | (1.22) | 0.97 | (1.19) | 1.03 | (1.29) | 0 | 4 | 31.9 | 0.543 |
| 5. I have had discharge in my ear. | Ear symptoms | 0.63 | (1.15) | 0.75 | (1.14) | 0.90 | (1.30) | 0 | 4 | 42.3 | 0.453 |
| 6. I have heard a buzzing or ringing sound in my ear (tinnitus). | Hearing | 1.20 | (1.16) | 1.31 | (1.14) | 1.38 | (1.15) | 0 | 4 | 17.8 | 0.431 |
| 7. I have experienced dizziness or disequilibrium. | Balancea | 0.53 | (0.88) | 0.66 | (0.95) | 0.69 | (1.02) | 0 | 4 | 38.0 | 0.343 |
| 8. I have experienced vertigo. | Balancea | 0.25 | (0.67) | 0.24 | (0.60) | 0.30 | (0.74) | 0 | 3b | 63.2c | 0.160d |
| 9. My hearing has worsened. | Hearing | 1.50 | (1.31) | 1.64 | (1.32) | 1.62 | (1.29) | 0 | 4 | 17.8 | 0.639 |
| 10. I have had problems hearing because of background noise. | Hearing | 1.67 | (1.39) | 1.75 | (1.37) | 1.71 | (1.34) | 0 | 4 | 16.6 | 0.624 |
| 11. I have had difficulty locating the direction of a sound. | Hearing | 1.31 | (1.39) | 1.40 | (1.38) | 1.32 | (1.33) | 0 | 4 | 26.4 | 0.651 |
| 12. I have been using a hearing aid due to hearing loss. I find this challenging. | Hearing | 0.14 | (0.61) | 0.13 | (0.59) | 0.12 | (0.53) | 0 | 4 | 78.5c | 0.233d |
| 13. I have had difficulty hearing a phone or an alarm clock. | Hearing | 0.70 | (1.10) | 0.73 | (1.11) | 0.71 | (1.09) | 0 | 4 | 47.9c | 0.555 |
| 14. I have had trouble in group discussions because of my hearing. | Hearing | 1.18 | (1.29) | 1.25 | (1.28) | 1.16 | (1.24) | 0 | 4 | 25.2 | 0.654 |
| 15. Protecting my ear from water has restricted my life. [If you do not protect your ear from water, select “DCM.”] | Need for carea | 0.63 | (1.14) | 0.64 | (1.14) | 0.65 | (1.13) | 0 | 4 | 49.1c | 0.179d |
| 16. Because of my ear problems, I do not socially interact as much with other people. | Quality of life | 0.80 | (1.12) | 0.86 | (1.15) | 0.78 | (1.07) | 0 | 4 | 37.4 | 0.654 |
| 17. Because of my ear problems, I face challenges in my daily activities/at school/at work. | Quality of life | 0.92 | (1.19) | 1.04 | (1.20) | 1.03 | (1.16) | 0 | 4 | 31.9 | 0.667 |
| 18. Symptoms related to my ears limit my hobbies. | Quality of life | 0.59 | (1.04) | 0.69 | (1.09) | 0.68 | (1.10) | 0 | 4 | 40.5 | 0.502 |
| 19. I fear that the symptoms related to my ears will worsen in the future. | Quality of life | 1.44 | (1.37) | 1.53 | (1.34) | 1.48 | (1.35) | 0 | 4 | 17.2 | 0.581 |
| 20. My ear problems make me sad. | Quality of life | 0.92 | (1.16) | 1.02 | (1.22) | 1.03 | (1.23) | 0 | 4 | 31.3 | 0.607 |
| 21. I feel like my ear problems have negatively affected my quality of life. | Quality of life | 1.10 | (1.15) | 1.24 | (1.15) | 1.19 | (1.16) | 0 | 4 | 23.3 | 0.709 |
| 22. I have consulted a doctor because of my ear problems. | Need for carea | 0.76 | (0.89) | 1.40 | (1.22) | 1.86 | (1.34) | 0 | 4 | 26.4 | 0.304 |
| 23. I have used oral antibiotics because of my ear problems. | Need for carea | 0.06 | (0.33) | 0.25 | (0.70) | 0.45 | (0.93) | 0 | 4 | 76.1c | 0.324 |
| 24. I have used antibiotic ear drops (as prescribed). | Need for carea | 0.35 | (0.68) | 0.69 | (1.10) | 1.08 | (1.36) | 0 | 4 | 58.3c | 0.366 |
Group includes Balance and Need for care
whole scale was not used from 0 to 4 (Q8)
% “DCM” (“Doesn’t concern me”) and 0 exceeds 50 in most diagnostic groups (Q8, Q12, Q13, Q23)
ITC is below 0.3 in most diagnosis groups (Q8).